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1. Introduction 
Cancer is one of the most important public health problem in Mexico and worldwide, 
especially for female population, breast and cervical cancer (CC) types are the most 
frequent. Incidence rates of CC are higher in developing countries 40/100,000 women per 
year vs. 10/100,000 in developed countries (1). In Mexico there are 12,000 new reports cases 
every year (2). The absence of the screening programs or comparatively ineffective screening 
programs lead to relatively late diagnosis of the disease and also in differences in the human 
papillomavirus (HPV) infection (3). Several types of HPV are associated with CC worldwide 
(4, 5), being the HPV16 the most frequent oncogenic type.  
Epidemiological and experimental studies suggest that high risk HPV have an important 
role in cervical carcinogenesis. Persistent viral infection, genetic background in combination 
with constitutive expression of the viral oncogenes as E6 and E7, are decisive steps for 
malignant transformation, because these oncoproteins interact with the tumour suppressor 
proteins p53 and pRB, respectively for their degradation (6, 7). Finally, these interactions 
could induce cellular proliferation and genetic instability for example, which could promote 
the accumulation of mutations and aneuploidy (8). In conclusion, viral oncoproteins have a 
general impact in global profile of expressed genes, which could be analyzed by high-
throughput methodologies. One of these techniques is DNA oligonucleotide-based 
microarray technology, which allows a rapid and high-throughput detection of thousands of 
transcripts simultaneously (9-11).  
It has been published several studies about gene expression profiles in HPV infected cells. 
Mainly these reports are based on gene expression levels altered by E6 and E7 HPV 
oncoproteins (12-17). Regarding changes in gene expression profiles in cervical cancer 
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samples, there are a few papers comparing normal cervical expressed genes versus tumors 
samples (12, 18), the major aim in those studies was to find potential tumor markers with 
clinical value. At present the list of the potential markers is short (p16, survivin). 
We have published some works about alterations in gene expression in CC (19, 20). In those 
reports we observed that WNT pathway, calcium pathway and some cellular proteases 
(MMP11, cathepsin F) could be involved in cervical carcinogenesis. Thus, these findings are 
contributing to our knowledge about alterations in CC pathogenesis. 
In the present work our microarray data obtained from microarray assay on CC samples 
(20) were newly managed and analyzed by using new bioinformatics suite programs and 
then, to get others genes altered in cervical cancer, as well as to define signaling pathways 
probably implicated in this type of cancer.   
2. Material and methods 
Biological samples. Eight squamous CC tissues stage IIB (according of International 
Federation of Obstetrics and Gynecology, FIGO) HPV16 positive were selected and two 
healthy “normal” cervical samples were originally studied. The normal samples were 
collected after hysterectomy by uterine myomatosis without HPV infection history. All 
DNAs from healthy and cervical cancer samples were subjected to PCR by using general 
oligonucleotides against to HPV; and to confirm the HPV type, the positive samples were 
then sequenced  (data not shown). An important point to eliminate negative false, only the 
samples harboured at least 70% of tumour cells or normal epithelial cells were analyzed.  
Total RNA was extracted from squamous CC and normal tissues using TRIzol reagent 
(GIBCO, BRL, USA). RNA was synthesized and labeled with CodeLink Express Assay 
Reagent Kit (Applied Microarrays, GE Healthcare, USA). 
2.1 Microarray platform 
CodeLink™ Human Whole Genome Microarrays offer comprehensive coverage of the 
Human genome, this array have ~57,000 probes and consider transcripts and ESTs 
(expression tagged sequences). In this system are included: 1,200 genes for oncogenesis 
process, 1,400 for cell cycle, 1,000 for cell-signaling, 3,000 for metabolism, 1,400 for 
developmental process, 2,700 of transcription and translation, 1,100 for immune and 
inflammation response, 800 for protein phosphorylation, 600 for apoptosis, 1,150 for ion 
transport, 400 for synaptic transmission, 200 for kinases, among other.  
This array harbors 45,674 genes (based on unique UniGene IDs), 360 positive controls, 384 
negative controls, 100 housekeeping genes, one specific and functionally validated probe 
and the oligonucleotide probe length of 30-mer. 
This platform has been applied in different biological models (21-23). CodeLink Bioarray are 
recently introduced, single-color oligonucleotide microarrays, which differ from Affymetrix 
GeneChips in the following aspects: 1) this Bioarray use a single pre-synthesized, pre-
validated 30-mer probe to detect each target transcript, whereas Gene-Chips use multiple in-
situ synthesized, 25-mer probes; and 2) the surface of CodeLink Bioarrays is made of 3-
dimensional aqueous gel matrix, whereas that of Affymetrix GeneChips is made of 2-
dimensional glass matrix. These characteristics could suggest that CodeLink Bioarrays 
behave differently from GeneChips and may require different normalization strategies from 
the ones optimized for GeneChips (24)(Figure 1). 
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Fig. 1. General strategy of microarray analysis on cervical cancer samples. Originally RNA 
samples from normal epithelial cells or CC lesions were subjected to hybridization reaction 
on arrays. The data were analyzed by using different bioinformatics Tools to obtain 
differentially expressed genes. 
3. Analysis of the data 
Partek® Genomics SuiteTM is a comprehensive suite of advanced statistics and interactive 
data visualization specifically designed to reliably extract biological signals from noisy data. 
The commercial software is unique in supporting all microarray and next generation 
sequencing technologies including gene expression and digital gene expression, 
exon/alternative splicing, RNA-Seq, copy number and association, ChIP-chip, ChIP-seq, 
and microRNAs in a single software package, allowing for analysis of multiple applications 
in one complete solution. 
www.intechopen.com
 Computational Biology and Applied Bioinformatics 
 
262 
This kind of analysis will provide results with minimal noises generated from the internal 
controls. To perform this analysis is necessary to apply a software suite which is composed 
by three different statistical tests: Probe Statistical algorithm (MAS5), Probe Logarithmic 
Intensity Error (Plier) and Robust Multichip Analysis (RMA). The goal of these tests is to 
establish differences and similarities between internal controls and to get the most real data. 
In the present case, the normalized samples were analyzed RMA statistical tests eliminating 
the tags harboring variations. 
In the global gene expression is difficult understand what happen with all of genes in 
different cellular process including the cancer, in this context a way of visualization data is a 
Principal Component Analysis or PCA (25). This method is a mathematical technique to 
reduction the effect of the gene expression sample in a small dimensional space, when there 
is less changes in the global gene expression the dimensional is smaller. Next for 
visualization of changes in gene expression in all samples we made a clustering analysis 
(26), in this method we used a K-means algorithm and let to classify to determine similitude 
and dissimilitude in all samples, to finish we applied methods of systems biology as 
Ingenuity Pathway Analysis) and gene classification to determine new list of candidates for 
subsequent lab verification and might help in the search for a cure for cancers. 
3.1 Networks by Ingenuity Pathways Analysis (IPA) 
This software (www.ingenuity.com) to help life science researchers explore, interpret, and 
analyze complex biological Systems, and is used to help researchers analyze 'omics data and 
model biological systems. This analysis was to identify Networks of interacting genes and 
other functional groups. A cut-off ratio of 2 was used to define genes. 
4. Results  
The best and most accurate method for identifying disease-causing genes is monitoring gene 
expression values in different samples using microarray technology. One of the 
shortcomings of microarray data is that they provide a small quantity of samples with 
respect to the number of genes. This problem reduces the classification accuracy of the 
methods, so gene selection is essential to improve the predictive accuracy and to identify 
potential marker genes for a disease. Among numerous existing methods for gene selection, 
PARTEK has become one of the leading methods, but its performance can be reduced 
because of the small sample size, noisy data and the fact that the methods remove 
redundant genes. 
The original cervical dataset was already published and available in a previous report (20). 
This dataset was obtained by using CodeLink microarray platform and provides the 
expression levels of 57,000 probes for 2 normal tissues and 8 cervical cancers HPV16 
positive. The data were pre-processed by carrying out a base 10 logarithmic transformation 
and normalized (see Figure 2). After first analysis of the data, using significance analysis of 
microarrays 3,248 genes well annotated were identified. 
After that, the data already normalized were managed and analyzed using Partek genomics 
suite version 6.5 (Partek GS) obtaining a list of differentially expressed genes (Tumor versus 
Normal). Specific and new procedures are actually performed in analysis of microarray 
data. For instance, after internal control analysis, the raw data are normalized using the 
common software available on line or some other like Partek GS. This suite provides 
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rigorous and easy-to-use statistical tests for differential expression of genes or exons, and a 
flexible and powerful statistical test to detect alternative splicing based on a powerful mixed 
model analysis of variance.  
By one-side ANOVA statistical test a small group of 208 genes were selected with a false 
discovery ratio < 10%, from these, 111 overexpressed genes with a fold change >2, and 97 
downregulated genes with a fold change of <-2 genes were observed (Tables 1 and 2).  
 
 
  
 
A) 
 
 
 
 
 
B) 
Fig. 2. Normalization data set. The values of gene expression were normalyzed by medians. 
A) Left image is showing the normalization of positive internal controls harboured in the 
bioarray. The right image is showing the normalization of negative internal controls of the 
array.  As example, these figures corresponds to a normal samples. 
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Table 1. List of genes and EST’s (without gene name) up-regulated 
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Id G e n e  N a m e F o ld -C h a n g e
S C G B 1 D 2 s e c r e t o g lo b in ,  f a m i l y  1 D ,  m e m b e r  2 - 1 8 6 . 6 8 6
K R T 4 k e r a t i n  4 - 1 7 3 . 8 7 6
F O S F B J m u r in e  o s t e o s a r c o m a  v i r a l  o n c o g e n e  h o m o lo g - 1 3 8 . 0 6 2
M A L m a l ,  T - c e l l  d i f f e r e n t i a t io n  p r o t e i n - 1 3 3 . 1 7 3
W I S P2 W N T 1  i n d u c ib le  s ig n a l in g  p a t h w a y  p r o t e i n  2 - 9 0 . 6 2 4 2
U N Q 6 9 8 s u p r a b a s in - 8 8 . 3 6 3 2
F L J2 2 6 5 5 R E R G / R A S - l i k e - 8 8 . 2 0 8 6
S PA R C L 1 S PA R C - l i k e  1  ( h e v in ) - 8 6 . 9 8 8 7
M G C 4 5 7 8 0 s c a v e n g e r  r e c e p t o r  c l a s s  A ,  m e m b e r  5  ( p u t a t i v e ) - 7 8 . 2 2 0 5
R G S 5 r e g u la t o r  o f  G - p r o t e in  s ig n a l in g  5 - 7 3 . 2 3 8
M A M D C 2 M A M  d o m a in  c o n t a in in g  2 - 6 9 . 9 8 7 9
I G F B P6 in s u l i n - l i k e  g r o w t h  f a c t o r  b in d in g  p r o t e in  6 - 6 8 . 8 7 6 5
C 1 o r f 1 0 c o r n u l in - 6 7 . 0 5 8 4
F H L 1 f o u r  a n d  a  h a l f  L I M  d o m a in s  1 - 6 4 . 6 3 3 8
T N A C - t y p e  l e c t in  d o m a in  f a m i l y  3 ,  m e m b e r  B - 5 9 . 3 4 0 5
W 5 7 6 5 5 - - 5 7 . 5 2 8 8
PL A C 9 p la c e n t a - s p e c i f i c  9 - 5 1 . 9 8 9 6
D F c o m p le m e n t  f a c t o r  D  ( a d ip s in ) - 5 0 . 8 3 1 7
U N Q 4 6 7 k e r a t i n o c y t e  d i f f e r e n t ia t i o n - a s s o c ia t e d  p r o t e i n - 5 0 . 2 5 3 3
PT G D S p r o s t a g la n d in  D 2  s y n t h a s e  2 1 k D a  ( b r a i n ) - 5 0 . 1 3 4 8
S C G B 2 A 2 s e c r e t o g lo b in ,  f a m i l y  2 A ,  m e m b e r  2 - 4 9 . 6 3 3
D PT d e r m a t o p o n t in - 4 7 . 7 0 4 8
C R I S P3 c y s t e i n e - r i c h  s e c r e t o r y  p r o t e i n  3 - 4 6 . 6 0 4 8
B N C 2 b a s o n u c l in  2 - 4 6 . 1 5 3 8
O G N o s t e o g l y c in - 4 4 . 5 3 0 8
E D N 3 e n d o t h e l i n  3 - 4 2 . 5 1 6 1
D PT d e r m a t o p o n t in - 3 8 . 5 7 1 2
F X Y D 1 F X YD  d o m a in  c o n t a in i n g  i o n  t r a n s p o r t  r e g u la t o r  1 - 3 6 . 7 6 5 5
PPP1 R 3 C p r o t e i n  p h o s p h a t a s e  1 ,  r e g u la t o r y  ( in h ib i t o r )  s u b u n i t  3 C - 3 5 . 3 0 7 3
O S R 2 o d d - s k ip p e d  r e l a t e d  2  ( D r o s o p h i la ) - 3 4 . 3 5 1 2
A N K R D 2 5 K N  m o t i f  a n d  a n k y r in  r e p e a t  d o m a in s  2 - 3 2 . 6 4 0 6
B F 9 4 1 6 7 7 - - 3 0 . 9 5 0 3
M I T F m ic r o p h t h a lm ia - a s s o c ia t e d  t r a n s c r ip t i o n  f a c t o r - 3 0 . 7 0 0 2
B Q 0 0 7 0 7 4 - - 3 0 . 1 0 1 1
A L 1 3 7 5 6 6 - - 2 9 . 8 3 3
F B L N 5 f ib u l in  5 - 2 9 . 4 4 9 4
PG M 5 p h o s p h o g lu c o m u t a s e  5 - 2 8 . 8 1 9 2
C R YA B c r y s t a l l i n ,  a lp h a  B - 2 8 . 3 0 9 4
M F A P4 m ic r o f ib r i l l a r - a s s o c ia t e d  p r o t e in  4 - 2 7 . 6 3 5 7
A A 1 0 1 6 3 2 - - 2 7 . 2 7 8 4
C O L E C 1 2 c o l le c t in  s u b - f a m i l y  m e m b e r  1 2 - 2 6 . 3 8 1 3
PC O L C E 2 p r o c o l la g e n  C - e n d o p e p t id a s e  e n h a n c e r  2 - 2 6 . 1 8 5 1
C O L 1 4 A 1 c o l la g e n ,  t y p e  X I V ,  a l p h a  1 - 2 5 . 1 7 4 5
A R H G A P6 R h o  G T Pa s e  a c t i v a t in g  p r o t e i n  6 - 2 4 . 9 4 1 5
A E B P1 A E  b in d in g  p r o t e i n  1 - 2 4 . 5 7 3 8
T E N C 1 t e n s in  l i k e  C 1  d o m a in  c o n t a in i n g  p h o s p h a t a s e  ( t e n s in  2 ) - 2 2 . 8 4 1 3
A N G PT L 2 a n g io p o ie t i n - l i k e  2 - 2 2 . 7 6 9 2
C O L 4 A 1 c o l la g e n ,  t y p e  I V ,  a l p h a  1 - 2 2 . 2 2 7 8
L M O 3 L I M  d o m a in  o n ly  3  ( r h o m b o t i n - l i k e  2 ) - 2 2 . 0 8 2 2
N D R G 2 N D R G  f a m i l y  m e m b e r  2 - 2 1 . 5 6 0 7
F L J1 0 9 7 0 t r a n s m e m b r a n e  p r o t e i n  1 0 0 - 2 1 . 5 0 5 4
C L C A 4 c h lo r i d e  c h a n n e l  a c c e s s o r y  4 - 2 1 . 3 4 1 2
C O X 7 A 1 c y t o c h r o m e  c  o x id a s e  s u b u n i t  V I I a  p o ly p e p t i d e  1  ( m u s c le ) - 2 0 . 3 2 9 5
M I T F m ic r o p h t h a lm ia - a s s o c ia t e d  t r a n s c r ip t i o n  f a c t o r - 2 0 . 1 9 7 6
G N G 1 1 g u a n in e  n u c le o t id e  b in d in g  p r o t e in  ( G  p r o t e i n ) ,  g a m m a  1 1 - 2 0 . 1 2 1 1
T A C C 1 t r a n s f o r m in g ,  a c i d ic  c o i le d - c o i l  c o n t a in in g  p r o t e i n  1 - 1 9 . 9 8 5 1
E C G 2 s e r i n e  p e p t i d a s e  in h ib i t o r ,  K a z a l  t y p e  7  ( p u t a t i v e ) - 1 9 . 9 0 9 5
A I 7 3 4 2 1 2 - - 1 9 . 5 2 7
A I 7 6 5 6 3 7 - - 1 9 . 1 4 1 6
E B F e a r ly  B - c e l l  f a c t o r  1 - 1 8 . 9 8 3 2
B A I 3 b r a in - s p e c i f i c  a n g io g e n e s is  i n h ib i t o r  3 - 1 8 . 8 9 8 5
A R H G A P2 8 R h o  G T Pa s e  a c t i v a t i n g  p r o t e in  2 8 - 1 8 . 5 6 5 4
K C N A B 1 t a s s iu m  v o l t a g e - g a t e d  c h a n n e l ,  s h a k e r - r e l a t e d  s u b f a m i l y ,  b e t a  m e m b e - 1 8 . 2 3 7 9
A A 5 7 8 9 8 2 - - 1 8 . 1 5 9 6
C E C R 6 c a t  e y e  s y n d r o m e  c h r o m o s o m e  r e g io n ,  c a n d id a t e  6 - 1 8 . 0 4 7 6
A F 3 2 1 9 7 6 - - 1 7 . 2 4 9 9
E D N 3 e n d o t h e l i n  3 - 1 6 . 2 8 9 6
M YL K m y o s in  l i g h t  c h a in  k i n a s e - 1 6 . 0 1 7 5
C 7 c o m p le m e n t  c o m p o n e n t  7 - 1 5 . 7 4 7 3  
Table 2. List of genes and EST’s (without gene name) down-regulated 
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4.1 Analyzing microarray data with novel software suite 
If we want to display the data in just two dimensions, we want as much of the variation in 
the data as possible captured in just two dimensions. Principal component analysis or PCA 
has been developed for this purpose. Applying this PCA method in the cervical data we 
observed some expected differences (Figure 3). 
 
 
Fig. 3. Principal component analysis of cervical cancer samples. As expected, after perform 
PCA analysis, the normal samples (red balls) were grouped out of CC Group (blue balls) in 
a 3-D image. 
In order to obtain a graphical representation of the differences between normal and tumor 
tissues, hierarchical cluster analysis was performed on all samples with a pseudo-color 
visualization matrix of the 208 selected genes grouping with greater intra-group similarity 
and differences between groups. The phylogenetic tree resulting from the hierarchical 
complete linkage-clustering algorithm is shown in figure 4. The figure shows those genes 
that are changing respect to health cervical tissue. In this method of clustering, allows to do 
relationships among objects (genes or samples) and are represented by a tree whose branch 
lengths reflect the degree of similarity between the objects, as assessed by a pairwise 
similarity function. The computed trees can be used to arrange individual samples in the 
original data table; this allows the samples or groups of samples with similar expression 
patterns to be shown adjacent to each other.  
In general, tumor samples showed heterogeneity among them compared with normal 
samples, which had a more homogeneous gene expression profile. So, clustering analysis in 
CC failed to show significant segregation of patients based on expression profiling possibly  
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Fig. 4. Hierarchical clustering of the gene expression data for cervical tissues. Clustering 
analysis were performed for all tumours and normal samples. The data were clustered using 
the standard hierarchical method with ward linkage and using the Perason correlation to 
determine distance tumour. Before clustering, the data was filtered to remove genes that 
were scored absent in 75% or more of the samples as they are likely to be measuring noise in 
the system. The cluster of normal samples exhibit nearly identical patterns of gene 
expression changes, on contrary, as expected the invasive samples grouped in a different 
branch showing a heterogeneous gene expression. Blue color indentify downregulation and 
red color an overexpression status. 
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due to the heterogeneous nature of the samples as well as the relatively small numbers of 
samples in this study. Even when the samples were subjected to rigorous procedures of 
analysis, the special selection of the patients, including age, clinical stage, HPV16 positive 
and contraceptive oral status avoiding any bias, in this stage of the carcinogenesis process 
(stage IIb) the pattern of gene expression is quite different between samples. 
 
 
 
Table 3. Disease and Disorders functions in cervical cancer 
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We used IPA to investigate the biological relevant of the observed genome-wide expressed 
gene changes by categorizing our data set into biological functions and/or diseases 
Ingenuity Pathway analysis was applied. The 208 genes annotated list by PARTEK analysis 
was submitted to the visualization IPA tool. This bioinformatics tool is employed for 
visualizing expression data in the context of KEGG biological pathways; the importance IPA 
is that retrieves an impact factor (IF) of genes that entire pathway involved, which can help 
to obtain a clearer notion of the alteration level in each biological pathway, and understand 
the complexity of these different process of the cancer cell. We imported a list of 
significantly up and down regulated genes (with extension .txt) into the program to convert 
the expression data into illustrations in an attempt to explore altered mechanisms in CC. To 
overcome any possible incorrect IF in altered pathways due to different size of samples, we 
submitted a similar quantity of up and down regulated genes. This allowed confirming that 
genes involved in several metabolic pathways were altered in CC (see networks).  
We were able to associate biological functions and diseases to the experimental results. 
Fifteen pathways were obtained with a high score. Table 3 is showing the genes and the top 
three disorders/disease of “small networks” based in the analysis of the data. As can be 
seen, a clear route in cancer as it is known was not observed but some genes have been 
previously associated; however, these data give important information involving “non 
canonical” pathways in cancer.  
Finally, in the Figure 5 is showed a “hypothetical network in CC” based from the 15 small 
networks. In addition to gene expression values, the proposed method uses Gene Ontology, 
which is a reliable source of information on genes. The use of Gene Ontology can 
compensate, in part, for the limitations of microarrays, such as having a small number of 
samples and erroneous measurement results. 
5. Discussion 
In our results, non classical “cancer genes” were conserved, respect to expected genes as 
MYC, FOS, RB, P53, HIF, etc. However, in the “strict sense of the word” when is considered 
a cancer gene? By instance, over-expression, down-regulation, point mutation, 
amplification, loss of heterozygosity, polymorphisms, epigenetic changes, etc. Thus, any 
gene could be considered like cancer gene, if they are following special criteria as recently 
was reported (27). 
In this context, we decided to explore two non-related genes in cervical cancer PARK2 gene. 
Interestingly, PARK2 gene mutations (point mutations and exonic deletions) were first 
identified in autosomal recessive juvenile-onset parkinsonism. This gene is mapped to 
6q25.2-q27 containing 12 small exons, and encodes parkin protein which functions as an E3 
ligase, ubiquitinating proteins for destruction by the proteosome. Several substrates for 
parkin have been identified, including a 22kD glycosolated form of synuclein, parkin-
associated endothelin receptor-like receptor (Pael-R), and CDCrel-1. Over-expression of 
Pael-R causes it to become ubiquinated, insoluble, and unfolded, and lead to endoplasmic 
reticulum stress and cell death (for review see 28). The location of Parkin is in a 
chromosomal region that is frequently deleted in multiple tumor types, including 
hepatocellular carcinoma (HCC), ovarian cancer, and breast cancer. The Parkin gene is 
within FRA6E, the third most active common fragile site (29,30). Interestingly, all three 
fragile sites regions were found consistently deleted in HCC (31) as well as in ovarian, 
breast, and prostate cancers. Further PARKIN protein overexpression did not lead to  
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Fig. 5. Networks in cervical cancer. Top three networks diagrams generated as graphical 
representations of the molecular relationship between genes and gene product. The gene 
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products are represented as nodes (shapes) and the biological relationship between two 
nodes is represented as an edge (line). A) Network 1. skeletal and muscular system 
development and function, embryonic development, tissue development, B) network 2; 
dermatological diseases and conditions, cardiovascular disease, organismal injury and 
abnormalities, C) network 3; cell cycle, organismal functions, organismal injury and 
abnormalities, D) Ingenuity Pathways Analysis network of genes associated with CC. This 
network diagram shows the biological association of 8 focus networks associated with 
cervical cancer as graphical representation of the molecular relationship between 
genes/gene produtcs. 
increased sensitivity to all pro-apoptotic induction but may show specificity for a certain 
type of cellular stress. At present, Parkin gene could be considered as new tumor suppressor 
gene (32). In our case, per se Parkin expression in CC is interesting. It is widely described 
that p53 master gene is constitutively expressed but under stress conditions as HPV 
infection, DNA damage or point mutations its half-time life of the protein is increased. 
Similar situation might be observed for Parkin gene due to increased expression in CC. This 
could be supported because the 6q25 cytogenetic region in CC is not altered as happen for 
TP53 gene (33). To this respect, we could hypothesize that a new overexpression of Parkin 
gene could be involved in invasion cervical carcinogenesis. These findings could 
demonstrate that the genetic context in which a mutation occurs can play a significant role 
in determining the type of illness produced or associated. 
It has been established that although we inherit two copies of all genes (except those that 
reside on the sex chromosomes), there is a subset of these genes in which only the paternal 
or maternal copy is functional. This phenomenon of monoallelic, parent-of-origin expression 
of genes is termed genomic imprinting. Imprinted genes are normally involved in 
embryonic growth and behavioral development, but occasionally they also function 
inappropriately as oncogenes and tumor suppressor genes (34). Furthermore, it is well know 
that a variety of genetic changes influence the development and progression of cancer. 
These changes may result from inherited or spontaneous mutations that are not corrected by 
repair mechanisms prior to DNA replication. It is increasingly clear that so called epigenetic 
effects that do not affect the primary sequence of the genome also play an important role in 
tumorigenesis (35). 
Other gene overexpressed seen in this analysis was PEG10 gene. This gene is mapped in 
chromosme 7q21. PEG10 protein prevents apoptosis in hepatocellular carcinoma cells 
through interaction with SIAH1, a mediator of apoptosis. May also have a role in cell 
growth promotion and hepatoma formation. Inhibits the TGF-beta signaling by interacting 
with the TGF-beta receptor ALK1. This is a paternally expressed imprinted gene that 
encodes transcripts containing two overlapping open reading frames (ORFs), RF1 and 
RF1/RF2, as well as retroviral-like slippage and pseudoknot elements, which can induce a -1 
nucleotide frame-shift. Increased expression of this gene is associated with hepatocellular 
carcinomas. These findings link to cancer genetics and epigenetic by showing that a classic 
proto-oncogene, MYC, acts directly upstream of a proliferation-positive imprinted gene, 
PEG10 (36,37).  
The HOX genes are a family of transcription factors that bind to specific sequences of DNA 
in target genes regulating their expression. The role of HOX genes in adult cell 
differentiation is still obscure, but growing evidence suggests that they may play an 
important role in the development of cancer. We have previously reported that some HOX 
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genes could be related to CC. Specifically, HOXA9 was observed expressed in cervical 
cancer by RT-PCR end point. In the present work, the data are showing that statistically 
significative HOXA9 gene is differentially expressed in CC. Together to HOXB13, D9, D10, 
and HOXC cluster (HOXC9, C11–C13) genes this family of genes might be an important 
factor involved in CC (35). 
It is clear that the most altered genes in CC are not commonly associated to cancer process. 
This fact could suggest: 1) the “classic genes of cancer” are statistically significant altered 
with tiny values, but there are some exceptions and specific tumor types as neuroblastomas 
and N-MYC gene, Her2/neu in breast cancer. 2) At least in stage IIb of cervical carcinogenesis 
could be involved genes related to “cellular economy” but not belonging to genes of cancer. 
This is supported by recent reports showing molecular alterations in genes not previously 
related to cancer (27). 3) The extreme values (high or low) in microarray analysis not always 
represent strong candidates of markers in the models performed. What about the most 
frequent?. (4) Integrative genomics, multicentre protocols in well selected samples, stratified 
stages and clinical follow-up, will be the clue to get cancer hallmarks. In addition, the study 
of the molecular function of selected genes strengthened the hypothesis that these genes are 
involved in the process of cancer growth. 
The data information obtained from microarray analysis should be validated because can 
appear errors in positive and negative false due to nature of the massive assays. In this 
context, in order to confirm the microarray data, additional molecular tool as end point 
PCR, real time PCR, northern blot, immunohistochemistry should be performed and to 
obtain results. (Mendez S. An Integrative microarray gene expression analysis, approach 
identifies candidates’ array multi-experiments in Ovary Tumours, submitted to publication 
2011). 
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